Open AccessTenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India
Author(s) -
AtulK Patel,
KetanK Patel,
RajivR Ranjan,
ApurvaR Patel,
JagdishK Patel
Publication year - 2010
Publication title -
indian journal of sexually transmitted diseases and aids
Language(s) - English
Resource type - Journals
eISSN - 2589-0565
pISSN - 2589-0557
DOI - 10.4103/0253-7184.68998
Subject(s) - medicine , creatinine , renal function , regimen , fanconi syndrome , urology , cohort , gastroenterology , kidney
Tenofovir (TDF) is preferred nucleoside reverse transcriptase inhibitors (NRTI) for the treatment of human immunodeficiency virus infection because of its potency and safety. Renal toxicity with TDF use is low and comparable with other NRTI in clinical trials, but there are many case studies and small case series of renal dysfunction with TDF.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom